Honda Earnings Hammered By Recalls

Honda cut its full-year net profit forecast by 3.5% after being hit by costs related to recalls over explosive air bags made by Takata.

Valeant to Buy Prostate-Cancer Drug From Dendreon

Valeant Pharmaceuticals International said late Thursday it has reached a tentative deal to buy the prostate-cancer drug Provenge and other assets from Dendreon for $296 million in cash.

Google Reports Disappointing Revenue

The rising dollar claimed another victim as Google's revenue grew slower than expected. The Mountain View, Calif., Internet giant said 4Q revenue, excluding payments to other companies that syndicate its ads, rose 17% to $14.5 billion in the year-ago period, below estimates of $14.7 billion.

Amazon's Profit Drops Less Than Expected

Bucking tradition, the Seattle company posted higher-than-expected net income in last year's final quarter, despite sales growth below forecasts. Amazon typically has satisfied investors with rapidly-growing sales and investments, even at the expense of profits.

Canadian Oil Sands to Slash Dividend and Spending

Canadian Oil Sands said Thursday it would further slash its dividend and capital spending budget in response to the sharp drop in oil prices and a rising debt load.

Shake Shack Said to Price IPO at $21

Thanks to hearty investor appetite, Shake Shack's initial public offering priced well above expectations, netting the burger chain a valuation of $745.5 million.